Koninklijke Philips NV vs Sherwin-Williams Company (The) Common Stock — how do they compare? Koninklijke Philips NV trades at $25.18 (market cap $24.60B), while Sherwin-Williams Company (The) Common Stock trades at $326.97 (market cap $78.78B). The key difference: Sherwin-Williams Company (The) Common Stock is far larger — about 3.2× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (4.05%). Which is the better fit depends on your goals.
| PHG | SHW | |
|---|---|---|
Market Cap | $24.60B | $78.78B |
Volume | 1,105,836 | 1,403,311 |
Sector | Health | Basic Materials |
52-Week High | $32.91 | $372.60 |
52-Week Low | $23.81 | $293.00 |
Typical Hold Time | 84 Days | — |
Enterprise Value | $30.96B | $92.71B |
Dividend Yield | 4.05% | 0.99% |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.89, up 0.61% on the day, with a bullish technical signal despite mixed momentum indicators. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $0.57 surpassing the $0.40 forecast. Revenue for 2025 was $17.83 billion, with a net income margin of 5.01%, marking a significant recovery from prior losses. Positive news includes new product launches and a $33.7 million ARPA-H award for AI-enabled stroke care, enhancing growth prospects in health technology.
The outlook is cautiously optimistic, supported by earnings momentum and strategic innovations, but risks include high debt levels and competitive pressures. Analyst consensus is Hold-dominated, with 63.64% recommending Hold, indicating tempered expectations amid operational improvements and macroeconomic uncertainties.
Sherwin-Williams (SHW) trades at $324.10, up 1.21% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows neutral technical signals but maintains robust fundamentals with 65.12% ROE and expanding manufacturing capacity. Recent facility expansions in Statesville enhance production capabilities, positioning the company for continued market share gains.
Outlook remains positive with analyst consensus at Buy (57.9%) and $383.64 price target, though high valuation multiples (P/E 29.9) and competitive pressures present risks. Earnings growth and strategic investments support upside potential, while margin compression and economic sensitivity warrant monitoring.
Trailing returns across standard periods
Latest headlines on both assets
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →The Sherwin-Williams Company manufactures, develops, and distributes paints, coatings, and related products through three segments: Paint Stores Group, operating more than 4,900 company-owned stores selling Sherwin-Williams-branded products; Consumer Brands Group, selling brands such as Valspar, Dutch Boy, Krylon, and Minwax through mass merchandisers and home centers; and Performance Coatings Group, supplying industrial, construction, and transportation coatings in more than 120 countries.
Read more on SHW →